Editoriali
La posizione dell’Associazione Culturale Pediatri
sulla nuova influenza A/H1N1
L. Grandori, M. Gangemi
Ottobre 2009 - pagg. 483 -485
Classificazione MeSH
Bibliografia
1. Doshi P. Calibrated response to emerging infections. BMJ 2009;
339:b347.
2. CDC. Surveillance for Pediatric Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infection - United States, April-August
2009. MMWR 2009;58:941-7.
3. NSW-Health (Australia). Weekly Influenza Epidemiology Report. 29 July 2009.
4. Follin P, Lindqvist A, Nyström K, Lindh M. A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain. Euro Surveill 2009;14(24).pii:19242.
5. The 2009 Victorian Influenza Vaccine Effectiveness Audit Report. Victorian Infectious Diseases Reference Laboratory. Casistica al 13/9/2009; www.vidrl.org.au.
6. Greenberg ME, Lai MH, Hartel GF. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine - preliminary report. N Engl J Med 2009;361: Sep 10 (online).
7. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009;14 (31).pii:19288.
8. Shun-Shin M, Thompson M, Heneghan C, et al. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 2009;339:b3172.
2. CDC. Surveillance for Pediatric Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infection - United States, April-August
2009. MMWR 2009;58:941-7.
3. NSW-Health (Australia). Weekly Influenza Epidemiology Report. 29 July 2009.
4. Follin P, Lindqvist A, Nyström K, Lindh M. A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain. Euro Surveill 2009;14(24).pii:19242.
5. The 2009 Victorian Influenza Vaccine Effectiveness Audit Report. Victorian Infectious Diseases Reference Laboratory. Casistica al 13/9/2009; www.vidrl.org.au.
6. Greenberg ME, Lai MH, Hartel GF. Response after one dose of a monovalent influenza A (H1N1) 2009 vaccine - preliminary report. N Engl J Med 2009;361: Sep 10 (online).
7. Kelly H, Grant K. Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 2009;14 (31).pii:19288.
8. Shun-Shin M, Thompson M, Heneghan C, et al. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials. BMJ 2009;339:b3172.